Gita V. Massey MD

Pediatric Hematology & Oncology•Richmond, VA

Children's Hospital of Richmond (CHoR) Division of Pediatric Hematology-Oncology

Join to View Full Profile

1000 E. Broad ST - 1st floorPediatric Hematology-OncologyRichmond, VA 23298
Phone+1 804-828-9605
Fax+1 804-628-0070

Education & Training

Virginia Commonwealth University Health SystemFellowship, Hematology and Medical Oncology, 1985 - 1988
Virginia Commonwealth University Health SystemResidency, Pediatrics, 1981 - 1985
Virginia Commonwealth University School of MedicineClass of 1981

Certifications & Licensure

VA State Medical License 1986 - 2026
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
ACTIVE_NOT_RECRUITING
PHASE3
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Start of enrollment: 2000 Nov 06
Recruiting
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 14
ACTIVE_NOT_RECRUITING
PHASE3
Correlation Between Vitamin D Status and Bone Mineral Density in Patients With Hemophilia Start of enrollment: 2010 Mar 01
Completed
Not Applicable
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 09
Completed
Intergroup Trial for Children or Adolescents With B-Cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients Start of enrollment: 2012 Jun 01
Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma Start of enrollment: 2013 Feb 12
Completed
Phase 2
Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas Start of enrollment: 2013 Jun 17
COMPLETED
Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients. Start of enrollment: 2013 Aug 20
Completed
Phase 2
Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Start of enrollment: 2014 Jul 11
ACTIVE_NOT_RECRUITING
PHASE2, PHASE3
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 01
Join now to see all

Publications & Presentations

PubMed

Sociodemographic Characteristics of Patients Seen at Vascular Anomaly Centers in the United States.
Bryan A Sisk, Whitney Eng, Jamie Aye, Joana Mack, Andrew Tran
Pediatric Blood & Cancer. 2025-03-17
1 citations
Congenital dyserythropoietic anemia type IV with KLF1 E325K mutation: A new case with dysmorphic male genitalia.
Gita V Massey, Alden Chesney, Manisha Gadgeel, Yaddanapudi Ravindranath
Pediatric Blood & Cancer. 2024-06-01
Medich Giant Platelet Syndrome: An Evolving Qualitative and Quantitative Platelet Disorder.
Gita Massey, Laura Tyrrell, Yaser Diab, William T Gunning 3rd
Hematology Reports. 2022-12-01

Gita V. Massey MD

Dr. Massey is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Viewing the full profile is available to verified healthcare professionals only.